Self-monitoring blood glucose is relatively uncommon among diabetes patients in developing nations. Type 2 diabetics in countries including China and India, where the next massive wave of diabetes patients is emerging, typically don't monitor themselves on a daily basis as is the standard of care in developed economies. These patients receive occasional in-clinic monitoring--if any at all.
A staggering 400 million people have Type 2 diabetes globally, as the forces of urbanization induce massive dietary and lifestyle changes that underlie the disease. The vast majority of them have no access to self-monitoring technology for their blood glucose levels. Without that information to help keep their levels within an acceptable range, they are subject to major complications including blindness, loss of limbs and death.
Read Full Article »